SEPARATION AGREEMENTSeparation Agreement • April 7th, 2017 • Bioptix, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledApril 7th, 2017 Company Industry JurisdictionTHIS SEPARATION AGREEMENT (the "Agreement") is entered into as of the 6th day of April, 2017 (the "Effective Date") by and between Steve Lundy ("Employee") and Bioptix, Inc., a Colorado corporation, and subsidiaries (the "Company", and together with the Employee, the "Parties").